MENU
ARMP
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION

Armata Pharmaceuticals (ARMP) Earnings Date & Reports

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

ARMP is expected to report earnings to rise 95.00% to -38 cents per share on August 13

Armata Pharmaceuticals ARMP Stock Earnings Reports
Q2'25
Est.
$-0.39
Q1'25
Missed
by $0.04
Q4'24
Beat
by $0.06
Q3'24
Beat
by $0.13
Q2'24
Beat
by $0.12
The last earnings report on May 14 showed earnings per share of -20 cents, missing the estimate of -15 cents. With 7.30K shares outstanding, the current market capitalization sits at 71.66M.
View a ticker or compare two or three
ARMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of novel bacteriophage-based therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
5005 McConnell Avenue
Phone
+1 310 665-2928
Employees
66
Web
https://www.armatapharma.com